INTRODUCTION
Holding forth in this amphitheater is a true deja vu experience for me because years ago I conducted Grand Rounds many times from the very same podium. I am delighted to see that in the 18 years since my departure, the Fitkin amphitheater has retained the same threadbare gentility that characterized it during my tenure here as a student and house officer.
It is now almost 24 years to the day since I first met Paul Beeson. He had just arrived from Emory, where he had been Chairman of the Department of Medicine a few short days before. In order to get acquainted with the students and housestaff, he used to go to the housestaff dining room for his meals. He had heard of the industry and dedication of the Yale housestaff and since he believed that getting to know them was very important, on his first morning in New Haven he went to the dining room at 7:15 a.m. to join them for breakfast. To his surprise, none of the house officers was there. That impressed him a great deal because he figured that they were already on the wards, so the next morning he came in at 7:00 o'clock and again failed to find the housestaff. On the third day, he came in at 6:45 a.m. only to find the dining room closed. He eventually learned that the usual breakfast time for Yale house officers was closer to 8:15 than 7:15 [1] .
I first met him at dinner. It was a month or two before I was to graduate and I was subinterning on ENT, eating the usual diet of kale in which the dining room of the New Haven Hospital specialized at that time, when Beeson sat down with me. He had learned that I was going to be an intern on the medical service and asked what I was planning to do with my future. I allowed that I was interested in clinical medicine and teaching, and that perhaps that combination would be good enough for an academic career. He pointed out that the only true road to success was clinical investigation. He was certainly right about that at the time-in fact, he may still be right about it. Although my beginning with Beeson well as ever-rounding, teaching and doctoring, and I am delighted that the students and housestaff at Washington now have the same privilege of being exposed to Paul Beeson that we had when we were students and house officers at Yale (Fig. 1) .
THE EXPERIMENTAL MODEL When I arrived at the Radcliffe Infirmary in Oxford, Beeson and a young doctoral candidate in his laboratory, David Durack, had just modified the experimental model for endocarditis previously produced by Garrison and Freedman3 [3] . The GarrisonFreedman rabbit model consisted of a plastic polyethylene catheter that was inserted into the right heart through the femoral vein, filled with a culture of staphylococci, and subsequently sealed at the distal end. Several days after insertion of the catheter, the rabbits developed staphylococcal endocarditis in the area of the tricuspid valve. If the catheter was filled with sterile saline, small sterile vegetations developed at the site where the catheter was in contact with the valve in the endocardium. The BeesonDurack modification was as follows: Reasoning that bacterial endocarditis often developed when a pre-existing sterile vegetation was seeded by circulating organisms, they inserted a catheter into the right heart through the jugular vein and left it in place for 24-48 hours. By that time, a sterile vegetation had invariably formed. If a culture of virulent organisms was then injected intravenously, the bacteria lodged on the sterile vegetation, converting it to an infected vegetation. This model lent itself to ready quantification because the vegetation could be excised in toto, homogenized, and the number of organisms enumerated [4] .
A further modification of this model, which has been used by most investigators, consists of the production of left-sided endocarditis by the insertion of a catheter into the carotid artery and its placement in the aorta at the site of the aortic valve [5] . This invariably results in the formation of a sterile vegetation in the area of the aortic valve. The sterile vegetation provides a favorable nidus for colonization by circulating organisms. When streptococci were injected into the bloodstream, they lodged on the vegetation and entered a logarithmic phase of growth, while in organs such as the liver or spleen, they were gradually killed [4] .
Pathologically, the vegetations are remarkably like those found in man. They consist of a relatively amorphous mass of fibrin, platelets and platelet debris, and bacteria. Leukocytes are scanty. Organisms may be found deep within the fibrin matrix or, early in the infection, on the surface. When right-sided infection is produced with Streptococcus sanguis, about one-third of animals recover spontaneously, while the other two-thirds die with continuing infection and heart failure. On the left side of the heart, infection is progressive and death is almost invariable.
PREVENTION OF EXPERIMENTAL ENDOCARDITIS WITH ANTIBIOTICS
It is well known that cases of endocarditis may develop following dental manipulation, or surgery of the genital, urinary and gastrointestinal tracts. Chemoprophylaxis of bacterial endocarditis has therefore become accepted practice, but its efficacy has not been put to clinical trial. As a matter of fact, a clinical trial would be virtually impossible because of the relatively low incidence of bacterial endocarditis following bacteremia. Studies in an animal model therefore seemed to be the best alternative available. In our prophylaxis experiments [6, 7] we gave antibiotics 30 minutes before intravenous injection of bacteria into catheterized rabbits.
The experiments were performed with a strain of Streptococcus sanguis which was sensitive to 0.02 micrograms per ml of penicillin G. We thought, therefore, that the administration of penicillin to rabbits within 30 minutes of inducing bacteremia should prevent colonization of the vegetation. To our surprise, doses of aqueous penicillin that were comparable on a weight basis to those deemed to be effective in preventing infection in man were not effective in these rabbits (Table 1 ) [5] . In fact, not until very large does of penicillin were administered repeatedly was prevention achieved. We thought that the surprising failure of aqueous penicillin might be related to its rapid excretion, and for this reason procaine penicillin was tested. Again, however, this longer-acting form was ineffective until large doses-150,000 units per kilo, which is equivalent on a weight basis to about 20 million units in man-were used.
In view of the failure of procaine penicillin in ordinary doses, we wondered whether it might not be necessary to provide penicillin in the blood for a more prolonged period. For this reason, we gave the rabbits benzathine penicillin, a formulation which is excreted very slowly. However, it also was ineffective.
These data suggested that with penicillin an initial high peak followed by a demonstrable serum level for a relatively prolonged period of time was necessary for the drug to be effective. We tested this hypothesis by treating the animals with a combination of aqueous crystalline penicillin, which was excreted very rapidly, along with a modest dose of benzathine penicillin to provide relatively long exposure (Table  1) . This regimen worked in every instance. Measurements of serum levels in the animals showed that regimens that provided a high initial peak, followed by moderate levels for 12-24 hours were effective. These included large doses of procaine penicillin, and the combination of aqueous penicillin and benzathine penicillin. On the other hand, regimens that failed to achieve the high initial peak or to maintain an adequate level of drug in the animal's serum were not effective.
Attempts to simulate these serum levels in man showed that a single administration of procaine penicillin and repeated administration of penicillin V would not provide the initial peak. Only a combination of crystalline aqueous penicillin plus aqueous procaine penicillin provided the initial high peak and the relatively prolonged levels that we sought. Interesting as these data were, they did not provide us an ideal regimen for use in man because many dentists would not be willing to administer parenteral penicillin to their patients prior to dental manipulation or surgery. We therefore sought alternatives.
Among the several alternative bactericidal drugs tested, only vancomycin was uniformly effective. The reason for vancomycin's effectiveness is not solely the high level which could be achieved in serum. Other drug regimens that were not successful resulted in serum bactericidal dilutions in excess of those resulting from vancomycin. Vancomycin's effectiveness is probably related to its dual mechanism of action which we believe is both on the cell wall and on other components of the microorganism. Of the bacteriostatic drugs tested, none was effective despite the fact that the levels achieved with those drugs exceeded the minimum inhibitory concentrations severalfold.
In looking for an effective regimen, we harkened back to some experiments done by Hunter almost 30 years ago demonstrating that in vitro the combination of penicillin and streptomycin was more effective against sensitive viridans streptococci than penicillin alone [8] . Penicillin kills off the vast majority of a culture of sensitive organisms but leaves a number of persisters. These Repeated administration of a number of agents was then tested. These included pencillin V, ampicillin, erythromycin, tetracycline, clindamycin and cefazolin [7] . Although some of these regimens reduced the number of bacteria in vegetations, none was effective in preventing infection entirely.
Although penicillin V was not effective when given at 6-hourly intervals, we found one characteristic of this drug that made it attractive. While ampicillin was excreted rapidly, penicillin V was excreted more slowly and we worked on this observation to attempt to find an oral regimen that could be recommended for use in man. This program consists of the administration of a loading dose of penicillin V followed by four maintenance doses at 6-hourly intervals. Unfortunately, an effective oral alternative to penicillin is not yet at hand.
Of course, this model represents a severe test of the efficacy of any antibiotic regimen because we used an inoculum which would render virtually every animal infected-in other words, an ID1oo. Hence, the number of organisms injected in these experiments is greater than would be expected under natural circumstances in man. In a lengthy experiment we calculated the ID5o for this organism and determined that it was approximately 1055 bacteria. We then infected groups of animals with the lower inoculum and found that the lower inoculum made little significant difference in the relative response to the various drugs, with the exception that erythromycin, which had been ineffective at the higher inoculum size, was more effective at the lower one.
In summary, we extended our observations on the prophylaxis of streptococcal endocarditis to include the following:
1. Pen V is effective with a 2 gram loading dose and repeated administration. 2. Cefazolin is partially effective when used in combination with streptomycin. 3. Erythromycin may be a good second-line drug.
PREVENTION OF ENTEROCOCCAL ENDOCARDITIS
Next, let me turn briefly to a series of experiments that we have just completed on the prophylaxis of enterococcal endocarditis [10] . This is the organism that is most likely to cause endocarditis following operative procedures involving the urinary, genital and gastrointestinal tracts. A total of 11 strains of enterococci were studied in the rabbit model. Ninety-six percent of untreated animals were infected. Ampicillin alone left 67% infected and even when the drug was given repeatedly over 48 hours, 50% of animals remained infected. Gentamicin alone was not effective, but the combination of ampicillin and gentamicin or ampicillin and streptomycin was effective in preventing infection in approximately 80% of animals. High dose vancomycin was the best regimen tested, but a lower dose was less successful. Streptomycin plus the lower dose of vancomycin was very effective against strains that were not highly streptomycin resistant. Cefazolin was ineffective against two strains, even when combined with gentamicin.
There were notable variations between individual strains, and results in vivo could not always be predicted from in vitro sensitivity data. For example, cefazolin was ineffective at doses which gave serum levels that were well above the MIC's for the strains tested, while streptomycin alone prevented infection in about half the animals tested even though serum levels of streptomycin were well below the MIC's for these enterococci. These results indicate that the efficacy of prophylactic antibiotic regimens cannot be predicted reliably from in vitro MIC's.
There are a number of significant differences between this animal model and the clinical situation; it is therefore important that our findings on prophylaxis of bacterial endocarditis should not be extrapolated too literally to man. We have emphasized that the correct use of these experimental findings is to compare antibiotic regimens in vivo and rank them in order of efficacy. In other words, use of the rabbit model cannot define precisely which regimens will be successful in patients and which will fail, but it can indicate which regimens should provide the widest margin of safety [11] .
TREATMENT OF EXPERIMENTAL ENDOCARDITIS
I would next like to illustrate how this model can be used to evaluate therapeutic regimens [12, 13] . In the initial prophylaxis experiments we included a group of animals that did not receive antibiotics until 6 hours after injection of bacteria. Prophylactic regimens that were successful when given within 30 minutes of injecting bacteria failed after a 6-hour delay. Cure could only be achieved by giving repeated doses of penicillin. Synergism was demonstrated between penicillin and streptomycin in this short-term model for therapy of endocarditis [12] , and soon afterward was independently confirmed by Sande [14] . In order to simulate the situation in man more closely, we then interposed a longer delay between infection and treatment, allowing the vegetation to evolve for 48 hours before administering antibiotics. When these animals were treated with penicillin alone, it took approximately 10 days to sterilize the vegetations in 50% of the animals, and even after two weeks not all were cured. Penicillin and streptomycin cured half the animals in approximately 6 days, and all within two weeks. Animals from which the catheters were removed responded slightly better to therapy but in both instances penicillin and streptomycin was better than penicillin alone [12] .
STUDIES IN PROGRESS
Finally, I want to summarize briefly some of the studies that are presently in progress. We and others are trying to define the factors in pathogenesis affecting infectivity or susceptibility to bacterial endocarditis. It has been postulated that certain structural components of oral streptococci, namely dextrans, render them more likely to cause endocarditis by increasing their "stickiness" [15] . However, in some recent experiments we have shown this not to be the case. Taking a dextran-producing organism and removing dextran by selecting out a dextran-negative mutant made no difference to that organism's infectivity [16] .
We are looking at the role of humoral antibody in the pathogenesis of this infection. Bacterial endocarditis is an infection that progresses despite rising titers of antibody. It is presumed that antigen-antibody complexes are formed between the bacterial antigen and its antibody, and it may be these complexes that cause tissue damage, including nephritis [17] . They are also suspect in causing persistent infection on the heart valves. This subject has assumed particular importance recently because of the suggestion that immunization against oral streptococci may lead to the prevention of dental caries. The question then arises whether such immunization could alter susceptibility to endocarditis; this question can be examined conveniently in our rabbit model. We are in the process of doing some experiments to test the effect of prior immunization on the susceptibility of rabbits to bacterial endocarditis. If immunization renders animals more susceptible to infection, it would probably affect the eventual manufacture of these vaccines.
We have recently shown that serum-resistant strains of E. coli, that is, strains that are not susceptible to the bactericidal effect of serum, are much more prone to produce endocarditis than serum-sensitive strains of E. coli. It appears that this phenomenon is mediated by complement, because when rabbits genetically deficient in C6 were tested, a serum-sensitive strain that did not infect normal rabbits caused E. coli endocarditis in the C6 deficient rabbits. The bactericidal action of serum may be a major factor determining the relative rarity of endocarditis due to E. coli and other bacteria that are killed by serum [18] .
Sanford and his colleagues have devised a technique whereby they incubate excised dog heart valves with various bacteria. Gram-positive organisms, which are much more prone to cause endocarditis, stuck to the valve in greater numbers than gramnegative organisms. This is, of course, a somewhat artificial in vitro system, but the correlation with what happens in patients is noteworthy [19] .
The role of leukocyte and reticuloendothelial function in the development of infection has not been evaluated. Equally important is the question whether the infection can be caused or perpetuated by incomplete bacterial forms.
CONCLUDING REMARKS
I am sure that by now you have thought of any number of experiments that you yourself may want to do. This model is so simple to work with that it has in a sense become the "Volkswagen" of experimental infectious disease.
There are now at least a dozen groups in this country working on the problem, where in 1972 there were only two. The availability of this easily reproducible and quantifiable experimental model may make bacterial endocarditis one of the beststudied infections. Moreover, there is every likelihood that some of the results obtained will be applicable to man. In fact, the American Heart Association is currently reviewing their recommendations for SBE prophylaxis in the light of our findings.
Experimental endocarditis in rabbits is a good example of Beeson's great gift for identifying an important clinical problem and finding the right way to study it in the laboratory. He has scored again.
